Patents by Inventor Frederick Y. Luh

Frederick Y. Luh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220227843
    Abstract: The present invention provides binding molecules, including monoclonal antibodies, multi-specific antibodies, and antibody fragments, that specifically bind to the coronavirus, such as SARS-CoV-2, and methods of use thereof. In some aspects of the invention, the binding molecules are human antibodies, fragments, or derivatives thereof that specifically bind to SARS-CoV-2 spike protein. In some aspects of the invention, the binding molecules function to neutralize SARS-CoV-2. The present invention also relates to methods of using the binding molecules and compositions for diagnosis and treatment.
    Type: Application
    Filed: January 12, 2022
    Publication date: July 21, 2022
    Applicant: Antaimmu BioMed Co., Ltd.
    Inventors: San-Tai Shen, Ing-Chien Chen, Kuang-Kai Liu, Frederick Y. Luh